The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor

Anti-cancer Drugs
A D Didier, F Loor

Abstract

Among the compounds endowed with the capacity to reverse the P-glycoprotein (Pgp)-mediated multidrug resistance of cancer cells, a powerful agent was found to be the cyclosporin D derivative SDZ PSC 833. After in vivo treatment with SDZ PSC 833, mice showed a decreased tolerability to cyclosporin A (CsA), but also to ivermectin, a widely used polycyclic lactone pesticide of Streptomyces avermitilis origin. The sequels were suggestive of CsA- or ivermectin-induced central nervous system dysfunction; they were interpreted as caused by the neutralization of the Pgp at the blood-brain barrier level, implying that CsA and ivermectin were Pgp substrates. CsA was already known to display both Pgp substrate and Pgp inhibitor properties. It now appears that ivermectin may also inhibit Pgp function. When compared in short-term assays for Pgp function inhibition, which measure the restoration of the retention of two Pgp probes in multidrug-resistant (MDR) cells to their parental (Par) cell levels, ivermectin appeared only a few fold weaker that SDZ PSC 833 in the case of murine monocytic leukemia MDR-P388 cells and nearly as active as SDZ PSC 833 in the case of human lymphocytic leukemia MDR-CEM cells. Therefore, like CsA or FK-506, iverm...Continue Reading

Citations

Jun 21, 2007·Veterinary Research Communications·David J Brayden, Joanna Griffin
Jul 5, 2005·Molecular and Biochemical Parasitology·Bernadette F ArdelliRoger K Prichard
Feb 1, 2003·European Journal of Pharmacology·Alain RouletThierry Pineau
Sep 27, 2003·Molecular and Biochemical Parasitology·William J BlackhallRobin N Beech
May 5, 1998·Molecular and Biochemical Parasitology·M XuR Prichard
Nov 6, 1998·Molecular and Biochemical Parasitology·W J BlackhallR N Beech
Aug 23, 2001·Veterinary Parasitology·R Prichard, A Tait
Sep 19, 2003·International Journal of Antimicrobial Agents·Dominique KerboeufGeorg von Samson-Himmelstjerna
Jul 1, 1997·The Veterinary Journal·R Prichard
May 10, 2002·Journal of Veterinary Pharmacology and Therapeutics·A LifschitzC Lanusse
Feb 9, 2011·Antimicrobial Agents and Chemotherapy·Dominique Kerboeuf, Fabrice Guégnard
Dec 10, 2013·Veterinary Parasitology·Carlos LanusseAdrian Lifschitz
Jul 5, 2005·Expert Opinion on Investigational Drugs·F Loor
Jan 30, 2016·Parasites & Vectors·Pablo GodoyRoger K Prichard
Apr 5, 2011·European Journal of Pharmacology·Aili GaoWensheng Xiang
May 7, 2010·Blood Cells, Molecules & Diseases·Roberta RiccioniUgo Testa
May 12, 2009·Chemico-biological Interactions·Miriam PerezAna I Alvarez
Dec 1, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Anne LespineMichel Alvinerie
Jun 15, 2005·Journal of Veterinary Pharmacology and Therapeutics·J GriffinD J Brayden
May 3, 2007·Journal of Veterinary Pharmacology and Therapeutics·L OlsénP Larsson
May 13, 2008·Journal of Veterinary Pharmacology and Therapeutics·L AlvarezC Lanusse
Mar 7, 2006·Journal of Veterinary Pharmacology and Therapeutics·L OlsénH Tjälve
May 22, 2010·The Journal of Pharmacy and Pharmacology·Aili GaoYijun Yan
Jun 26, 1999·Annals of Emergency Medicine·K ChungW J Tsai
Aug 25, 2005·Veterinary Parasitology·Georg von Samson-Himmelstjerna, William Blackhall
Jul 31, 2012·Veterinary Parasitology·Ruofeng YanRoger K Prichard
Dec 1, 2012·International Journal for Parasitology. Drugs and Drug Resistance·Roger PrichardAnne Lespine
Feb 26, 2004·The Journal of Pharmacy and Pharmacology·Adrian L LifschitzCarlos E Lanusse
Jun 28, 2016·Pharmaceutical Development and Technology·Walter Javier StarkloffNoelia L Gonzalez Vidal
Jun 12, 2018·Expert Opinion on Drug Metabolism & Toxicology·Lisa ChedikOlivier Fardel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.